Bariatrics clinical trial - Rhythm Pharmaceuticals, Inc. - EMANATE

Status:

not yet enrolling

ClinicalTrials.gov:

NCT05093634

Rhythm Pharmaceuticals, Inc - RM-493-035: EMANATE

Drug

Setmelanotide/Placebo

Phase

III

Condition

Obesity